Arcus Biosciences: Q3 Earnings Insights


Arcus Biosciences RCUS reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:00 PM.

Here's what investors need to know about the announcement.


Arcus Biosciences beat estimated earnings by 17.54%, reporting an EPS of $-0.94 versus an estimate of $-1.14.

Revenue was down $1.58 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 1.26% increase in the share price the next day.

Here's a look at Arcus Biosciences's past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate -1 -1.16 -1.07 -1.04
EPS Actual -1.04 -1.09 -0.93 -0.90
Revenue Estimate 35.86M 24.97M 23.31M 21.89M
Revenue Actual 29.00M 25.00M 34.00M 33.58M

To track all earnings releases for Arcus Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!